Serial Number 98912297
686

Registration Progress

Application Filed
Dec 19, 2024
Under Examination
Approved for Publication
Jul 15, 2025
Published for Opposition
Jul 15, 2025
Registered

Attorney Assistance

Notice of Publication
Due: Aug 14, 2025 7 days

Trademark Image

Basic Information

Serial Number
98912297
Filing Date
December 19, 2024
Published for Opposition
July 15, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
686
Status Date
Jul 15, 2025
Application
Pending
Classes
005

Rights Holder

NOVARTIS AG

99
Address
CH-4002
Basel 4002
CH

Ownership History

NOVARTIS AG

Original Applicant
99
Basel CH

NOVARTIS AG

Owner at Publication
99
Basel CH

Legal Representation

Attorney
Maury M. Tepper, III

USPTO Deadlines

Next Deadline
7 days remaining
Notice of Publication
Due Date
August 14, 2025
Extension Available
Until September 14, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

8 events
Date Code Type Description Documents
Jul 15, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 15, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jul 9, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jun 10, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 9, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 8, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 8, 2025 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 19, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Additional Information

Design Mark
The mark consists of four hand prints with circles between the thumb and index fingers which form a stylized version of a square; the upper left hand print is magenta; the lower left hand print is maroon, the lower right hand print is gold and the upper right hand print is lavender, the circles are black; white appearing in the mark designates transparent areas and is not a feature of the mark.
Color Claim
The color(s) magenta, maroon, gold, lavender and black is/are claimed as a feature of the mark.

Classification

International Classes
005